NovoSeven® RT Coagulation Factor VIIa (Recombinant) Room Temperature Stable is indicated for:

- Treatment of bleeding episodes in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX and in patients with acquired hemophilia
- Prevention of bleeding in surgical interventions or invasive procedures in hemophilia A or B patients with inhibitors to Factor VIII or Factor IX and in patients with acquired hemophilia
- Treatment of bleeding episodes in patients with congenital FVII deficiency
- Prevention of bleeding in surgical interventions or invasive procedures in patients with congenital FVII deficiency

NovoSeven® RT is also provided with a sterile vial adapter and a pre-filled diluent syringe (named NovoSeven® RT with MixPro), which together serve as an alternative needleless reconstitution system. NovoSeven® RT package containing 1 vial of NovoSeven® RT powder and 1 pre-filled histidine diluent syringe with vial adapter.

For indications, dosing and other information, please refer to the prescribing information.